Fresenius Kabi Oncology Ltd.
USPTO PatentsView assignee record - 23 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Fresenius ranks #12,931 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 10 technology areas.
- #12,931
- of 49,997 US assignees by volume
- Top 44%
- by Innovation Score (37.2/100)
- 15.5
- avg claims per patent
- +9%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12931 · Foreign Corporation #12,931 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #12,931/49,997
- PHOTO-FINISH Federal-Mogul Nurnberg
- CPC-FOCUS A61P · 10 areas
- INNOV-THIN 37.2/100
- CLAIMS-RICH 15.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +9% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Federal-Mogul Nurnberg GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Fresenius’s 37.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Fresenius
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Fresenius Kabi… · this assignee
Fresenius Kabi… · this assignee
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Fresenius's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Fresenius?
Each dot is one of Fresenius’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fresenius’s own 15.5 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Fresenius's grants concentrate
Fresenius Kabi Oncology Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 65.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2019. By volume, Fresenius sits between Federal-Mogul Nurnberg GmbH and Fulian Yuzhan Precision Technology Co., Ltd..
Fresenius's three-year grant acceleration
Fresenius Kabi Oncology Ltd. shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Fresenius's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Federal-mogul Nur…
Federal-Mogul Nurnberg GmbH
23 patents
- Finch
Finch Technologies Ltd.
23 patents
- Foodmate B V
Foodmate B.V.
23 patents
- Fres- System USA
Fres-co System USA, Inc.
23 patents
- Fresh Products
Fresh Products, Inc.
23 patents
- Frogparking
Frogparking Limited
23 patents
- Fujikoshi Machine…
Fujikoshi Machinery Corp.
23 patents
- Fulian Yuzhan Pre…
Fulian Yuzhan Precision Technology Co., Ltd.
23 patents
- Fresenius Kabi On… ◀
Fresenius Kabi Oncology Ltd.
23 patents
What this shows Fresenius holds 23 patents at rank #12,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Fresenius
By rank, the assignees closest to #12,932 in granted patent volume.
- Federal-Mogul Nurnberg GmbH #12,928 · 23 patents
- Finch Technologies Ltd. #12,929 · 23 patents
- Foodmate B.V. #12,930 · 23 patents
- Fres-co System USA, Inc. #12,931 · 23 patents
- Fresh Products, Inc. #12,933 · 23 patents
- Frogparking Limited #12,934 · 23 patents
- Fujikoshi Machinery Corp. #12,935 · 23 patents
- Fulian Yuzhan Precision Technology Co., Ltd. #12,936 · 23 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Fresenius's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Fresenius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 17.4% |
| 2016 | 2 | 8.7% |
| 2017 | 2 | 8.7% |
| 2018 | 2 | 8.7% |
| 2019 | 1 | 4.3% |
| 2020 | 3 | 13.0% |
| 2021 | 3 | 13.0% |
| 2022 | 3 | 13.0% |
| 2023 | 2 | 8.7% |
| 2024 | 1 | 4.3% |
Which technologies does Fresenius Kabi Oncology Ltd. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Fresenius Kabi Oncology Ltd.'s patent record in context - here's where to go next.
- Fresenius Kabi Oncology Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 65.2% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #12,931 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Fresenius Kabi Oncology Ltd. against Federal-Mogul Nurnberg GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.